Welcome to the second issue of the Morgan Lewis Pharma Review, which summarizes key recent cases from the Federal Circuit and district courts that impact the pharma space, including Federal Circuit and district court decisions in Hatch-Waxman litigations, Federal Circuit reviews of IPR challenges to Orange book–listed patents, and appellate and district court decisions in pharma-related antitrust litigations.
We hope Pharma Review can serve as a one-stop source for your patent and antitrust pharma-related legal developments.